There are approximately 1,500 cancer centers in the U.S.
Only 57 are NCI Comprehensive Cancer Centers.
We are still one of them.
Dartmouth Cancer Center is proud to announce that our designation as a National Cancer Institute (NCI) Comprehensive Cancer Center has been renewed!
The Cancer Center Support Grant is a five-year, $13.9 million grant that provides continued support for Dartmouth Cancer Center’s award-winning clinical care and robust research missions. DCC is one of only 57 centers in the United States—and the only one located outside a major urban area—to have this prestigious Comprehensive designation. The NCI continues to recognize the Cancer Center for its leadership and resources, in addition to reaching the highest level and breadth of basic science and clinical research set by the NCI.
With a score of “Outstanding,” the NCI has renewed DCC’s Comprehensive Cancer Center designation through 2029, making it one of the longest-standing NCI-designated centers.
"We are entering our second half-century of continuous NCI designation!" said DCC Director Steven D. Leach, MD. "In renewing our grant and our designation, the NCI has affirmed that DCC provides the same level of cancer care and research as a major metropolitan Comprehensive Cancer Center, but with a small town, compassionate community face. This distinction is more than a title; extending our NCI designation means extending our legacy of making discoveries that are truly practice-changing, paradigm-shifting, and policy-influencing."
The funding under the NCI renewal will support advances in immunotherapy, the discovery of new treatments, engineering of new devices and imaging techniques, and introduction of new precision medicine and precision prevention approaches that will improve outcomes for patients at DCC and around the world. It will also enable outreach to rural areas and a better understanding of the particular needs of this unique population of people.
NCI Cancer Center Support Grant funding is one of the many sources that provide the $56 million in additional support for research awarded to members of the Cancer Center. Many of the advances developed by the clinicians and scientists through previous grant funding have led to new biotech startup companies that has put DCC in the top 10 in small business awards from the NCI that aim to "promote the translation, further development, and ultimate commercialization of new therapies and technologies that span the cancer research spectrum."
“Our Cancer Center thrives because of the people who come to work, engage and make each day a little bit better in our fight against cancer. Our renewal as an NCI Comprehensive Cancer Center is a reflection of all of us in all of our roles. Diversity of thought and experience in the lab and in the clinic benefit our daily endeavors and make us stronger as an organization,” says Leach.